Matthias Guckenberger, MD

Matthias Guckenberger, MD, is Chairman of the Department for Radiation Oncology, University Hospital Zurich (USZ), and Professor at the University of Zurich (UZH). Integration of advanced imaging and radiotherapy into multimodality treatment of lung cancer has been a major research focus, especially stereotactic body radiotherapy (SBRT) for early stage NSCLC and oligo-metastatic disease. Safety and efficacy was evaluated in prospective clinical trials, in large multi-institutional and national patterns of care analyses. Mathematical and imaging-based modeling of tumor and normal tissue response to radiotherapy has been another focus. Overall, research has been published in >400 peer-reviewed articles. He is currently serving as president-elect of the ESTRO society.

Disclosures: